NecstGen has partnered with Paris-based biotech Astraveus to evaluate the Lakhesys™ Benchtop Cell Factory™, a microfluidic-based platform aiming to simplify and scale CAR-T production. The collaboration will test the system’s potential to reduce cost, footprint, and manual steps in a GMP setting.
The partnership strengthens NecstGen’s role in advancing cell therapy manufacturing and highlights Astraveus’ vision for decentralized, efficient production.
Read more: https://necstgen.com/necstgen-and-astraveus-collaborate-to-evaluate-benchtop-cell-factory-technology-for-scalable-car-t-manufacturing/
Pioneering research at Leiden Faculty of Science awarded NWO grants Three bold ideas, one shared goal: advancing science for a better future From smarter drug delivery to cosmic...
From therapeutic mini proteins to pharma compliance services, international life sciences companies are choosing Leiden as the place to grow. Among them are VRG Therapeutics...
The Biotech Training Facility at Leiden Bio Science Park welcomed the Merck on Tour mobile lab, a travelling showcase of the latest life science innovations. Throughout the day,...